Zovia 1/35 NDC 51862-894

NDC codes

FDA NDC Directory

Product NDC (as listed)51862-894Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51862-0894Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51862-894-01	51862089401	1 BLISTER PACK in 1 PACKET (51862-894-01) / 1 KIT in 1 BLISTER PACKMarketed from Oct 16, 2020
51862-894-03	51862089403	3 BLISTER PACK in 1 CARTON (51862-894-03) / 1 KIT in 1 BLISTER PACKMarketed from Oct 16, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Zovia 1/35
Generic name (nonproprietary): ethynodiol diacetate and ethinyl estradiol tablets
Dosage form: Kit
Labeler: Mayne Pharma Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209548
Marketing start: Oct 16, 2020
Listing expires: Dec 31, 2026
Identifiers: Product ID 51862-894_cf45efe7-7a61-4d1e-a3d4-d43c65911c4cSPL ID cf45efe7-7a61-4d1e-a3d4-d43c65911c4cSPL set ID d0d2a9e9-e9ce-4a42-b429-5c1f9a544795RxCUI 310228, 748797, 748804, 748859

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N451862089401 followed by a unit qualifier and the quantity

Package 51862-0894-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 10, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Zovia 1/35 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Oral contraceptives are highly effective. Table 1 lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization and progestogen implants and injections, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates. (A) Among typical couples who initiate use of a method (not necessarily for the first time), the percentage who experience an accidenta…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 209548

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209548
Product	Strength	Form · route	Labeler	Product NDC
Zovia 1/35ethynodiol diacetate and ethinyl estradiol tablets	—	Kit	Dr. Reddys Laboratories Inc.	75907-087